Becton Dickinson (BDX)

NYSE Health Care Health Care Equipment S&P 500

$211.88

-1.67 (-0.78%)

Close of Nov 06, 2026 · end-of-day data

Source: Becton Dickinson's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$12.48B	$12.09B	$15.98B	$17.29B	$16.07B	$19.13B	$18.87B	$19.37B	$20.18B	$21.84B
Cost of revenue	$6.49B	$6.13B	$8.71B	$9.00B	$9.28B	$10.50B	$10.39B	$11.20B	$11.05B	$11.91B
Gross profit	$5.99B	$5.94B	$7.27B	$8.29B	$7.58B	$8.63B	$8.48B	$8.17B	$9.12B	$9.93B
Research & development	$828.00M	$770.00M	$1.00B	$1.06B	$1.04B	$1.28B	$1.26B	$1.24B	$1.19B	$1.26B
Selling, general & admin	$3.00B	$2.91B	$4.02B	$4.33B	$4.18B	$4.72B	$4.71B	$4.72B	$4.86B	$5.28B
Operating income	$1.43B	$1.52B	$1.51B	$1.76B	$912.00M	$2.25B	$2.28B	$2.11B	$2.40B	$2.58B
Interest expense	$388.00M	$521.00M	$706.00M	$639.00M	$528.00M	$469.00M	$398.00M	$452.00M	$528.00M	$613.00M
Pre-tax income	$1.07B	$976.00M	$1.17B	$1.18B	$414.00M	$1.69B	$1.78B	$1.66B	$2.00B	$1.88B
Income tax	$97.00M	-$124.00M	$862.00M	-$57.00M	$62.00M	$88.00M	$148.00M	$132.00M	$300.00M	$203.00M
Net income	$976.00M	$1.10B	$311.00M	$1.23B	$874.00M	$2.09B	$1.78B	$1.48B	$1.71B	$1.68B
EBITDA	$2.54B	$2.61B	$3.49B	$4.01B	$3.03B	$4.48B	$4.51B	$4.40B	$4.68B	$5.04B
EPS (basic)	$4.59	$4.70	$0.62	$4.01	$2.75	$6.92	$5.93	$4.97	$5.88	$5.83
EPS (diluted)	$4.49	$4.60	$0.60	$3.94	$2.71	$6.85	$5.88	$4.94	$5.86	$5.82
Diluted shares	217.54M	223.59M	264.62M	274.77M	282.40M	292.09M	287.36M	288.39M	291.01M	288.51M
Gross margin	48.0%	49.1%	45.5%	47.9%	47.1%	45.1%	44.9%	42.2%	45.2%	45.4%
Operating margin	11.5%	12.6%	9.4%	10.2%	5.7%	11.8%	12.1%	10.9%	11.9%	11.8%
Net margin	7.8%	9.1%	1.9%	7.1%	5.4%	10.9%	9.4%	7.7%	8.4%	7.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$1.54B	$14.18B	$1.14B	$536.00M	$2.83B	$2.28B	$1.01B	$1.42B	$1.72B	$567.00M
Receivables	$1.62B	$1.74B	$2.32B	$2.35B	$2.40B	$2.35B	$2.19B	$2.53B	$3.03B	$2.40B
Inventory	$1.72B	$1.82B	$2.45B	$2.58B	$2.74B	$2.74B	$3.22B	$3.27B	$3.84B	$3.15B
Total current assets	$6.37B	$18.63B	$7.41B	$6.66B	$8.97B	$8.84B	$8.14B	$8.68B	$10.47B	$9.26B
Goodwill	$7.42B	$7.56B	$23.60B	$23.38B	$23.60B	$23.89B	$24.62B	$24.52B	$26.46B	$25.96B
Total assets	$25.59B	$37.73B	$53.90B	$51.77B	$54.01B	$53.87B	$52.93B	$52.78B	$57.29B	$55.33B
Total current liabilities	$4.40B	$3.34B	$7.22B	$5.66B	$5.84B	$6.63B	$7.81B	$6.64B	$8.96B	$8.31B
Short-term debt	$1.00B	$203.00M	$2.60B	$1.31B	$707.00M	$500.00M	$2.18B	$1.14B	$2.17B	$1.56B
Long-term debt	$10.55B	$18.67B	$18.89B	$18.08B	$17.22B	$17.11B	$13.89B	$14.74B	$17.94B	$17.62B
Total debt	$11.55B	$18.87B	$21.50B	$19.39B	$17.93B	$17.61B	$16.07B	$15.88B	$20.11B	$19.18B
Total liabilities	$17.95B	$24.79B	$32.91B	$30.68B	$30.25B	$30.19B	$27.65B	$26.98B	$31.40B	$29.93B
Shareholders' equity	$7.63B	$12.95B	$20.99B	$21.08B	$23.77B	$23.68B	$25.28B	$25.80B	$25.89B	$25.39B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$2.56B	$2.55B	$2.87B	$3.33B	$3.54B	$4.65B	$2.47B	$2.99B	$3.84B	$3.43B
Capital expenditures	$693.00M	$727.00M	$895.00M	$957.00M	$769.00M	$1.19B	$973.00M	$874.00M	$725.00M	$760.00M
Free cash flow	$1.87B	$1.82B	$1.97B	$2.37B	$2.77B	$3.45B	$1.50B	$2.12B	$3.12B	$2.67B
Investing cash flow	-$669.00M	-$883.00M	-$15.73B	-$741.00M	-$1.23B	-$1.88B	-$3.22B	-$716.00M	-$5.51B	-$818.00M
Financing cash flow	-$1.76B	$10.98B	-$58.00M	-$3.22B	$22.00M	-$3.31B	-$736.00M	-$1.96B	$2.09B	-$3.62B
Dividends paid	$562.00M	$677.00M	$927.00M	$984.00M	$1.03B	$1.05B	$1.08B	$1.11B	$1.10B	$1.20B
Share buybacks	$0	$220.00M	$0	$0	$0	$1.75B	$500.00M	$0	$500.00M	$1.00B
Stock-based compensation	$196.00M	$174.00M	$322.00M	$261.00M	$236.00M	$229.00M	$233.00M	$259.00M	$247.00M	$258.00M
Depreciation & amortization	$1.11B	$1.09B	$1.98B	$2.25B	$2.12B	$2.23B	$2.23B	$2.29B	$2.29B	$2.46B

Income statement

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$5.09B	$4.71B	$5.04B	$4.99B	$5.44B	$5.17B	$4.48B	$4.73B	$8.30B	$5.25B	$4.71B	$4.98B
Cost of revenue	$3.39B	$2.68B	$2.74B	$2.68B	$2.95B	$2.93B	$2.62B	$2.49B	$4.27B	$2.84B	$2.56B	$2.67B
Gross profit	$1.70B	$2.03B	$2.30B	$2.31B	$2.49B	$2.23B	$1.86B	$2.23B	$4.03B	$2.41B	$2.15B	$2.31B
Research & development	$281.00M	$290.00M	$299.00M	$299.00M	$302.00M	$343.00M	$232.00M	$230.00M	$559.00M	$306.00M	$249.00M	$258.00M
Selling, general & admin	$1.14B	$1.21B	$1.19B	$1.20B	$1.26B	$1.32B	$1.12B	$1.16B	$1.84B	$1.39B	$1.21B	$1.26B
Operating income	$349.00M	$439.00M	$734.00M	$602.00M	$622.00M	$453.00M	$383.00M	$739.00M	$1.17B	$552.00M	$93.00M	$663.00M
Interest expense	$113.00M	$111.00M	$125.00M	$137.00M	—	$155.00M	$150.00M	$152.00M	—	$153.00M	$149.00M	$132.00M
Pre-tax income	$181.00M	$359.00M	$633.00M	$500.00M	$514.00M	$306.00M	$201.00M	$569.00M	$975.00M	$393.00M	$39.00M	$554.00M
Income tax	$28.00M	$77.00M	$96.00M	$13.00M	$114.00M	$3.00M	$43.00M	$118.00M	$52.00M	$11.00M	$76.00M	$102.00M
Net income	$108.00M	$281.00M	$537.00M	$487.00M	$400.00M	$303.00M	$308.00M	$574.00M	$493.00M	$382.00M	-$311.00M	$377.00M
EBITDA	$936.00M	$1.00B	$1.30B	$1.17B	$1.21B	$1.06B	$950.00M	$1.31B	$1.93B	$1.17B	$656.00M	$1.23B
EPS (basic)	$0.35	$0.97	$1.85	$1.68	$1.38	$1.05	$1.07	$2.00	$1.72	$1.34	$-1.11	$1.37
EPS (diluted)	$0.34	$0.96	$1.85	$1.68	$1.37	$1.04	$1.07	$2.00	$1.72	$1.34	$-1.11	$1.37
Diluted shares	2.02M	291.40M	290.34M	290.25M	152.00K	290.39M	287.74M	287.22M	-184.00K	285.85M	280.64M	275.16M
Gross margin	33.4%	43.1%	45.7%	46.2%	45.7%	43.2%	41.5%	47.3%	48.6%	45.9%	45.7%	46.5%
Operating margin	6.9%	9.3%	14.5%	12.1%	11.4%	8.8%	8.5%	15.6%	14.1%	10.5%	2.0%	13.3%
Net margin	2.1%	6.0%	10.6%	9.8%	7.4%	5.9%	6.9%	12.1%	5.9%	7.3%	-6.6%	7.6%

Balance sheet

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Cash & equivalents	$1.42B	$1.18B	$2.35B	$4.46B	$1.72B	$711.00M	$667.00M	$735.00M	$567.00M	$740.00M	$813.00M	$708.00M
Receivables	$2.53B	$2.27B	$2.56B	$2.60B	$3.03B	$2.64B	$3.03B	$2.94B	$2.40B	$2.51B	$2.21B	$2.36B
Inventory	$3.27B	$3.30B	$3.23B	$3.25B	$3.84B	$3.86B	$3.72B	$3.95B	$3.15B	$4.08B	$3.36B	$3.32B
Total current assets	$8.68B	$8.16B	$10.34B	$12.21B	$10.47B	$8.66B	$8.67B	$9.00B	$9.26B	$9.19B	$8.01B	$8.14B
Goodwill	$24.52B	$24.60B	$24.57B	$24.55B	$26.46B	$26.33B	$26.44B	$26.60B	$25.96B	$26.62B	$25.95B	$25.94B
Total assets	$52.78B	$52.27B	$54.16B	$55.58B	$57.29B	$54.66B	$54.47B	$54.90B	$55.33B	$54.84B	$50.83B	$50.73B
Total current liabilities	$6.64B	$7.54B	$7.33B	$6.61B	$8.96B	$7.66B	$7.69B	$8.16B	$8.31B	$8.76B	$8.51B	$9.40B
Short-term debt	$1.14B	$2.02B	$2.02B	$1.19B	$2.17B	$1.32B	$1.60B	$1.81B	$1.56B	$2.62B	$2.57B	$3.30B
Long-term debt	$14.74B	$14.09B	$15.99B	$18.13B	$17.94B	$17.44B	$17.67B	$17.53B	$17.62B	$16.92B	$14.71B	$13.51B
Total debt	$15.88B	$16.11B	$18.01B	$19.32B	$20.11B	$18.76B	$19.27B	$19.34B	$19.18B	$19.54B	$17.28B	$16.81B
Total liabilities	$26.98B	$26.94B	$28.51B	$29.71B	$31.40B	$29.46B	$29.23B	$29.43B	$29.93B	$29.56B	$26.70B	$26.32B
Shareholders' equity	$25.80B	$25.33B	$25.65B	$25.87B	$25.89B	$25.20B	$25.24B	$25.47B	$25.39B	$25.28B	$24.13B	$24.42B

Cash flow

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Operating cash flow	$1.32B	$855.00M	$514.00M	$1.30B	$1.18B	$693.00M	-$204.00M	$1.09B	$1.85B	$657.00M	—	$776.00M
Capital expenditures	$294.00M	$116.00M	$134.00M	$179.00M	$296.00M	$105.00M	$114.00M	$164.00M	$377.00M	$108.00M	$125.00M	$143.00M
Free cash flow	$1.03B	$739.00M	$380.00M	$1.12B	$882.00M	$588.00M	-$318.00M	$925.00M	$1.48B	$549.00M	—	$633.00M
Investing cash flow	$137.00M	-$233.00M	-$1.06B	-$288.00M	-$3.94B	$204.00M	-$192.00M	-$336.00M	-$494.00M	-$183.00M	—	-$241.00M
Financing cash flow	-$997.00M	-$862.00M	$1.71B	$1.12B	$124.00M	-$1.93B	-$39.00M	-$841.00M	-$809.00M	-$302.00M	—	-$577.00M
Dividends paid	—	$275.00M	$275.00M	$275.00M	—	$302.00M	$298.00M	$299.00M	—	$299.00M	$290.00M	$286.00M
Share buybacks	$0	$500.00M	$0	$0	$0	$750.00M	$0	$0	$250.00M	$250.00M	$2.00B	$0
Stock-based compensation	$58.00M	$83.00M	$60.00M	$53.00M	$51.00M	$90.00M	$41.00M	$48.00M	$79.00M	$91.00M	$58.00M	$55.00M
Depreciation & amortization	$587.00M	$561.00M	$571.00M	$568.00M	$586.00M	$607.00M	$567.00M	$575.00M	$756.00M	$614.00M	$563.00M	$564.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.